Table: Ono Pharm -9-MTH group results (IFRS)

ONO PHARMACEUTICAL

01/02/2019 03:00

Feb 1 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              223.20              200.57           280.00    
                   (+11.3 pct)         (+6.2 pct)       (+6.9 pct)  
  Operating           52.15               52.19            63.50    
                   (-0.1 pct)          (-2.1 pct)       (+4.6 pct)  
  Pretax              55.23               55.33            67.00    
                   (-0.2 pct)          (-1.5 pct)       (+4.8 pct)  
  Net                 43.13               41.44            52.00    
                   (+4.1 pct)          (-2.4 pct)       (+3.4 pct)  
  EPS Basic         83.90 yen           79.74 yen       101.14 yen  
  EPS Diluted       83.89 yen           79.74 yen                   
  Ann Div                               45.00 yen        45.00 yen  
  -Q2 Div           22.50 yen           25.00 yen                   
  -Q4 Div                               20.00 yen        22.50 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T